Awarded to an individual who has made a significant contribution in the field of PH throughout his/her lifetime.
Dr Stuart Rich MD is a cardiologist and Director of Northwestern Medicine’s Pulmonary Vascular Disease Programme at the Bluhm Cardiovascular Institute and a Professor of Medicine, Northwestern University Feinberg School of Medicine.
He is one of the world’s most recognised experts on pulmonary vascular diseases. For more than three decades he has dedicated his research and clinical efforts to finding better solutions for pulmonary hypertension.
Dr Rich completed his residency training in medicine at Washington University in St Louis, and fellowship in cardiology at the University of Chicago. His career began at the University of Illinois, where he was principal investigator for the National Institutes of Health (NIH) Registry on Primary Pulmonary Hypertension, the first of its kind, and has been the leader of the largest clinical centre in the US for evaluating and treating patients with pulmonary hypertension since 1980. Dr Rich has conducted cutting-edge research on the molecular mechanisms, epidemiology, clinical presentation, natural history and treatments of the disease and been at the forefront of the development of virtually every new treatment for pulmonary hypertension, as well as the use of therapeutic procedures and devices. His pioneering research has led to a greater understanding of all types of pulmonary hypertension.
He has published hundreds of clinical articles and book chapters on pulmonary hypertension and is co-founder of the Pulmonary Vascular Research Institute, a global health professional organisation committed to bringing advances in treating pulmonary vascular diseases to the developing world. In 2014 he received the Heart for Hope Legacy Award from the Pulmonary Hypertension Association. Dr. Rich’s clinical interests include: pulmonary hypertension, pulmonary vascular disease, pulmonary thromboembolism, adult congenital heart disease, right heart failure and complex and rare forms of heart diseases.
Awarded to one or more PVRI members for their continued support, engagement and contributions.
M.A. Qadar Pasha is Emeritus Scientist, ICMR, Genetics of High Altitude Disorders at the Institute of Genomics and Integrative Biology in Delhi, India. Dr. Pasha is interested in the physiological changes and genetic susceptibility associated with acclimatization to high altitude. He has identified several genetic polymorphisms in the Indian population that are linked to the ability to adapt to high-altitude. A parallel interest is the involvement of these genes and pathways in Chronic Obstructive Pulmonary Disorder.
His interest lies in the physiological changes and genetic susceptibility associated with acclimatization to high altitude. He has identified several genetic polymorphisms in the Indian population that are linked to the ability to adapt to high-altitude. A parallel interest is the involvement of these genes and pathways in Chronic Obstructive Pulmonary Disorder.
His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in wide range of publications in various national and international journals.
Qadar has worked tirelessly to establish the 'Leh Symposium' as the platform for assembly of global experts working in challenging area of high altitude research.